All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F13%3A10188933" target="_blank" >RIV/00216208:11110/13:10188933 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064165:_____/13:10188933

  • Result on the web

    <a href="http://dx.doi.org/10.1111/add.12219" target="_blank" >http://dx.doi.org/10.1111/add.12219</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1111/add.12219" target="_blank" >10.1111/add.12219</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy

  • Original language description

    Background and aims Cross-study comparisons of effect sizes suggest that varenicline is more effective than nicotine replacement therapy (NRT) in aiding smoking cessation, but evidence from direct comparisons is limited. This study compared biochemicallyverified 52-week sustained abstinence rates in smokers attending the same clinical service according to whether they used varenicline or NRT in their quit attempt. Methods This was a prospective cohort study of 855 smokers attending a large smoking cessation clinic who used their choice of NRT product or varenicline in their quit attempt. All received the same behavioural support programme and chose their medication option (n=519 varenicline; n=336 NRT). The primary outcome measure was self-report of 52 weeks' abstinence following the target quit date confirmed by expired air carbon monoxide concentration. Baseline measures included socio-demographic variables, mental health diagnoses, measures of smoking, cigarette dependence and past

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FN - Epidemiology, infection diseases and clinical immunology

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/ME09014" target="_blank" >ME09014: Tobacco Dependence Treatment in the Czech Republic according to The Mayo Nicotine Dependence Center (NDC) experience: systematic implementation and evaluation, comparison with NDC</a><br>

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2013

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Addiction

  • ISSN

    0965-2140

  • e-ISSN

  • Volume of the periodical

    108

  • Issue of the periodical within the volume

    8

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    6

  • Pages from-to

    1497-1502

  • UT code for WoS article

    000321616800022

  • EID of the result in the Scopus database